Drug class
Kinase Inhibitor
Mechanism of action
Kinase Inhibitors
General use cases
- Melanoma
- adult patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, in combination with vemurafenib
- adult patients with histiocytic neoplasms
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
